Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy

Lee, Jeannette Y.; Dhakal, Ishwori; Casper, Corey; Noy, Ariela; Palefsky, Joel M.; Haigentz, Missak; Krown, Susan E.; Ambinder, Richard F.; Mitsuyasu, Ronald T.
November 2016
Journal of Cancer Epidemiology;11/2/2016, p1
Academic Journal
The objective of this study was to explore the cancer incidence rates among HIV-infected persons with commercial insurance who were on antiretroviral therapy and compare them with those rates in the general population. Paid health insurance claims for 63,221 individuals 18 years or older, with at least one claim with a diagnostic code for HIV and at least one filled prescription for an antiretroviral medication between January 1, 2006, and September 30, 2012, were obtained from the LifeLink® Health Plan Claims Database. The expected number of cancer cases in the general population for each gender-age group (<30, 30–39, 40–49, 50–59, and >60 years) was estimated using incidence rates from the Surveillance Epidemiology and End Results (SEER) program. Standardized incidence ratios (SIRs) were estimated using their 95% confidence intervals (CIs). Compared to the general population, incidence rates for HIV-infected adults were elevated (SIR, 95% CI) for Kaposi sarcoma (46.08; 38.74–48.94), non-Hodgkin lymphoma (4.22; 3.63–4.45), Hodgkin lymphoma (9.83; 7.45–10.84), and anal cancer (30.54; 25.62–32.46) and lower for colorectal cancer (0.69; 0.52–0.76), lung cancer (0.70; 0.54, 0.77), and prostate cancer (0.54; 0.45–0.58). Commercially insured, treated HIV-infected adults had elevated rates for infection-related cancers, but not for common non-AIDS defining cancers.


Related Articles

  • Hodgkin Lymphoma in HIV Positive Patients. Mounier, Nicolas; Spina, Michele; Spano, Jean P. // Current HIV Research;Mar2010, Vol. 8 Issue 2, p141 

    Hodgkin Lymphoma (HL) represents one of the most common types of a non-AIDS-defining tumour that occurs in the HIV population, and its incidence is increasing in the post Highly Active Anti-retroviral Therapy (HAART) era. Despite the aggressiveness of that disease, the outcome of patients with...

  • Diagnostic yield of fine-needle aspiration cytology in HIV-infected patients with lymphadenopathy in the era of highly active antiretroviral therapy. Lowe, S. M.; Kocjan, G. I.; Edwards, S. G.; Miller, R. F. // International Journal of STD & AIDS;Aug2008, Vol. 19 Issue 8, p553 

    Fine-needle aspiration (FNA) cytology has an established role in the investigation of lymphadenopathy in HIV-infected patients. However, changes in the spectrum of disease have been observed since the introduction of highly active antiretroviral therapy (HAART). The aim of the study was to...

  • ORBITAL RHABDOMYOSARCOMA IN A 10-YEAR OLD HIV POSITIVE CHILD. H, Adil; S. T., Khairy-Shamel; I., Shatriah; I., Mohtar; E., Zunaina; S., Bakiah; Y., Rohaizan; A. W., Mohd Shuhaimi; A. P., Hilol; J., Hasnan // Malaysian Journal of Medical Sciences;Jan2007 Supplement, Vol. 14, p216 

    Introduction: Human immunodeficiency virus (HIV) infected patients are at risk of developing cancer, particularly Kaposi's sarcoma and non-Hodgkin's lymphoma. In contrast, rhabdomyosarcoma is the commonest primary orbital tumour in premorbidly healthy children. This case illustrates an uncommon...

  • Soaring anal cancer incidence in the combination ART era. Mascolini, Mark // Research Initiative/Treatment Action!;Winter2013, Vol. 18 Issue 2, p5 

    People with HIV infection have strikingly higher anal cancer incidence and prevalence than people the same age in the general population. From the dawn of the HIV epidemic through the early combination antiretroviral therapy (cART) era, researchers calculate that HIV-positive women had more than...

  • High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort. Besson, Caroline; Lancar, Remi; Prevot, Sophie; Brice, Pauline; Meyohas, Marie-Caroline; Marchou, Bruno; Gabarre, Jean; Bonnet, Fabrice; Goujard, Cécile; Lambotte, Olivier; Boué, François; Mounier, Nicolas; Partisani, Marialuisa; Raffi, Francois; Costello, Régis; Hendel-Chavez, Houria; Algarte-Genin, Michele; Trabelsi, Selma; Marchand, Lucie; Raphael, Martine // Clinical Infectious Diseases;11/1/2015, Vol. 61 Issue 9, p1469 

    Background: Human immunodeficiency virus (HIV) infection is associated with a high risk of classical Hodgkin's lymphoma (cHL) in the combined antiretroviral therapy (cART) era. Methods: We analyzed the characteristics and outcome of HIV-associated cHL diagnosed in the modern cART era. The French...

  • Safety, Tolerability and Effectiveness of Generic HAART in HIV-Infected Children in South India. N. Kumarasamy; Kartik K. Venkatesh; Bella Devaleenol; S. Poongulali; S. N. Mothi; Suniti Solomon // Journal of Tropical Pediatrics;Jun2009, Vol. 55 Issue 3, p155 

    HIV-infected children in resource-limited settings are increasingly gaining greater access to highly active antiretroviral therapy (HAART) but documented longitudinal data remains limited. We aimed to study the clinical and immunological outcomes among 67 South Indian HIV-infected children with...

  • Effects of Antiretroviral Agents on Lipid Panels. Song, Jessica C. // AIDS Alert;Dec2007, Vol. 22 Issue 12, p139 

    The article focuses on the impact of highly active antiretroviral therapy (HAART) on lipid panels of HIV-infected patients.

  • South African study shows how few eligible patients start ART.  // PharmacoEconomics & Outcomes News;2/20/2010, Issue 597, p2 

    The article discusses a study by I. V. Bassett et al published in the January 2010 issue of the journal "AIDS" which indicated the number of eligible patients who start antiretroviral therapy (ART) during the first year of being diagnosed with HIV.

  • Kaposi Sarcoma–Associated Immune Reconstitution Inflammatory Syndrome: In Need of a Specific Case Definition. Letang, Emilio; Naniche, Denise; Bower, Mark; Miro, Jose M. // Clinical Infectious Diseases;Jul2012, Vol. 55 Issue 1, p157 

    A letter to the editor is presented in response to the article "Paradoxicalimmune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection by C.J. Achenbach in a 2011 issue.


Other Topics